Patents Assigned to Kabi Pharmacia AB
  • Patent number: 5190759
    Abstract: A composition for the prevention of adhesions between body tissues after a surgical operation, containing dextran and hyaluronic acid. The composition further claims the use of said components for the preparation of such a composition as well as its use as an agent for the prevention of adhesions.
    Type: Grant
    Filed: October 22, 1990
    Date of Patent: March 2, 1993
    Assignee: Kabi Pharmacia AB
    Inventors: Gert Lindblad, Peter Buckley
  • Patent number: 5188835
    Abstract: The invention concerns an intravaginal device comprising a combination of 17.beta.-estradiol and a supporting matrix for treating hypoestrogenic women. The device releases continously 17.beta.-estradiol at a rate of about 0.5 to about 25 .mu.g/24 h. The invention also comprises a method of preparing the device and a method of treating hypoestrogenic women by using the device.
    Type: Grant
    Filed: November 12, 1991
    Date of Patent: February 23, 1993
    Assignee: Kabi Pharmacia AB
    Inventors: Inga M. Lindskog, Bengt C. H. Sjogren, Sven-Borje Andersson
  • Patent number: 5182081
    Abstract: A test strip having at least one patch thereon and intended for use in occlusive epicutaneous testing in order to detect contact allergy to formaldehyde. The characteristic feature is that on at least one of the patches the test substance is a reversible N-formaldehyde derivative of succinimide which is formulated in a dry buffered vehicle.
    Type: Grant
    Filed: February 1, 1990
    Date of Patent: January 26, 1993
    Assignee: Kabi Pharmacia AB
    Inventors: Kurt Hedegaard, Sten Albrectsen, Jens Hansen
  • Patent number: 5135540
    Abstract: An intraocular lens having a substantially circular optical portion and two separate fixation arms each having an inner end and an outer free end. The fixation arms are each attached to the optical portion via a short connecting member which extends substantially radially from the optical portion circumference and is of approximately the same thickness and flexibility as the fixation arm to which it is attached.
    Type: Grant
    Filed: October 30, 1991
    Date of Patent: August 4, 1992
    Assignee: Kabi Pharmacia AB
    Inventors: Siebe J. Schepel, Lieuwe P. Jonkman
  • Patent number: 5114971
    Abstract: 11-epi PGF.sub.2 alpha esters are employed in treating glaucoma or ocular hypertension.
    Type: Grant
    Filed: October 23, 1990
    Date of Patent: May 19, 1992
    Assignee: Kabi Pharmacia AB
    Inventors: Johan W. Stjernschantz, Bahram Resul
  • Patent number: 5087424
    Abstract: An apparatus for facilitating the release of an ingredient of a plastic or elastic sample of a pharmaceutical or confectionery material while the sample is in contact with a liquid medium which includes a base, a fixed lower jaw, a movable upper jaw and a member for moving the upper jaw toward and away from the lower jaw, a support for mounting and supporting a sample in the space between the upper surface of the lower jaw and the lower surface of the upper jaw, and a container surrounding both the jaws and sample so as to confine a liquid medium to the area surrounding the sample.
    Type: Grant
    Filed: August 1, 1989
    Date of Patent: February 11, 1992
    Assignees: Kabi Pharmacia AB, Akstiebolaget Leo.
    Inventor: Lars R. Liljewall
  • Patent number: 5077069
    Abstract: The present invention provides for a composition of natural antioudants comprising tocopherol, ascorbic acid, citric acid and phospholepeds which are useful in oxidation of oils.
    Type: Grant
    Filed: January 7, 1991
    Date of Patent: December 31, 1991
    Assignee: Kabi Pharmacia AB
    Inventors: Stephen S. Chang, Kejian Wu